Cytokinetics Inc (CYTK)
66.82
+1.24
(+1.90%)
USD |
NASDAQ |
Apr 24, 16:00
66.82
0.00 (0.00%)
After-Hours: 20:00
Cytokinetics Max Drawdown (5Y): 53.24% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| March 31, 2024 | 53.24% |
| February 29, 2024 | 53.24% |
| January 31, 2024 | 53.24% |
| December 31, 2023 | 65.00% |
| November 30, 2023 | 65.00% |
| October 31, 2023 | 65.00% |
| September 30, 2023 | 65.24% |
| August 31, 2023 | 65.24% |
| July 31, 2023 | 65.24% |
| June 30, 2023 | 65.24% |
| May 31, 2023 | 65.24% |
| April 30, 2023 | 65.24% |
| March 31, 2023 | 65.24% |
| February 28, 2023 | 65.24% |
| January 31, 2023 | 65.24% |
| December 31, 2022 | 65.24% |
| November 30, 2022 | 65.24% |
| October 31, 2022 | 65.24% |
| September 30, 2022 | 65.24% |
| August 31, 2022 | 65.24% |
| July 31, 2022 | 65.24% |
| June 30, 2022 | 65.24% |
| May 31, 2022 | 65.24% |
| April 30, 2022 | 65.24% |
| March 31, 2022 | 65.24% |
| Date | Value |
|---|---|
| February 28, 2022 | 65.24% |
| January 31, 2022 | 65.24% |
| December 31, 2021 | 65.24% |
| November 30, 2021 | 65.24% |
| October 31, 2021 | 65.24% |
| September 30, 2021 | 65.24% |
| August 31, 2021 | 65.24% |
| July 31, 2021 | 65.24% |
| June 30, 2021 | 65.24% |
| May 31, 2021 | 65.24% |
| April 30, 2021 | 65.24% |
| March 31, 2021 | 65.24% |
| February 28, 2021 | 65.24% |
| January 31, 2021 | 65.24% |
| December 31, 2020 | 65.24% |
| November 30, 2020 | 65.24% |
| October 31, 2020 | 65.24% |
| September 30, 2020 | 65.24% |
| August 31, 2020 | 65.24% |
| July 31, 2020 | 65.24% |
| June 30, 2020 | 65.24% |
| May 31, 2020 | 65.24% |
| April 30, 2020 | 65.81% |
| March 31, 2020 | 65.81% |
| February 29, 2020 | 68.66% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
53.24%
Minimum
Jan 2024
87.11%
Maximum
Apr 2019
66.92%
Average
65.24%
Median
May 2020
Max Drawdown (5Y) Benchmarks
| Amgen Inc | 24.86% |
| Johnson & Johnson | 27.36% |
| Eli Lilly and Co | 22.48% |
| Viking Therapeutics Inc | 89.26% |
| Madrigal Pharmaceuticals Inc | 82.20% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 43.14 |
| Beta (5Y) | 0.6804 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 88.33% |
| Historical Sharpe Ratio (5Y) | 0.5889 |
| Historical Sortino (5Y) | 1.781 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 21.95% |